Cargando…
Chronic Experimental Diabetes Accelerates Urinary Elimination of Deprenyl and its Metabolites
Many diabetic patients take several medications to treat diabetes-associated complications and other ailments. The mode of elimination of these drugs and their metabolites are poorly understood. The elimination of deprenyl, a MAO-B inhibitor, used for the treatment of the early stage of Parkinson’s...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Bentham Science Publishers Ltd.
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2709476/ https://www.ncbi.nlm.nih.gov/pubmed/19662137 http://dx.doi.org/10.2174/1874104500802010001 |